Turn Therapeutics Inc. (TTRX) SEC Filings — 2025
11 SEC filings for Turn Therapeutics Inc. (TTRX) in 2025.
Filings
- Turn Therapeutics' Losses Mount Amid Cash Infusion, Going Concern Doubt — 10-Q · Nov 13, 2025
- Turn Therapeutics Files 8-K — 8-K · Nov 12, 2025
- Turn Therapeutics Inc. 8-K Filing — 8-K · Nov 4, 2025
- Turn Therapeutics Inc. Files 8-K for Name Change — 8-K · Oct 30, 2025
- Turn Therapeutics Enters Material Definitive Agreement — 8-K · Oct 28, 2025
- Turn Therapeutics Inc. Files 8-K — 8-K · Oct 22, 2025
- Turn Therapeutics Files S-1 for GEM Share Sales, Eyes Drug Approvals — S-1 · Oct 9, 2025
- Turn Therapeutics Reports Key Corporate Changes — 8-K · Oct 2, 2025
- Turn Therapeutics Eyes Nasdaq Direct Listing for PermaFusion Platform — S-1/A · Sep 24, 2025
- Turn Therapeutics to Direct List on Nasdaq, Eyes Drug Development — S-1/A · Sep 16, 2025
- Turn Therapeutics to Direct List on Nasdaq, Founder Retains Control — S-1 · Sep 2, 2025